Home
About
- About Molecure S.A.
- Our Team
R&D
Patients
Investors & media
Careers
Contact
- Whistleblowers

RB nr 30 Otrzymanie zgody amerykańskiej Institutional Review Board na badanie kliniczne II fazy dla związku OATD-01

About us

Molecure is an innovative biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.